SCHEMBL28039596

SCHEMBL28039596

NC(=O)c1ccc2c(c1)CCC=N2

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.43
SIRT2 Q8IXJ6 2/20 0.38
TSHR P16473 1/20 0.38
PARP1 P09874 4/20 0.37
HSD17B3 P37058 1/20 0.37
NNMT P40261 2/20 0.36
LCK P06239 1/20 0.36
MKNK1 Q9BUB5 1/20 0.35
MKNK2 Q9HBH9 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HSD17B10 Q99714 1/20 0.35
CDC7 O00311 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRK1 P41145 1/20 0.34
TRPA1 O75762 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23012008 0.87 KDM1A (0.41) KDM1ASIRT2TSHRPARP1HSD17B3
SCHEMBL25171204 0.85 ALDH1A1 (0.49) KDM1ATSHRKDM4EALDH1A1HSD17B10
SCHEMBL28314063 0.80 ALDH1A1 (0.42) KDM4EALDH1A1TRPA1
SCHEMBL2116517 0.72 TSHR (0.40) KDM1ASIRT2TSHRPARP1HSD17B3
SCHEMBL21168435 0.70 HSD17B3 (0.55) KDM1ASIRT2TSHRPARP1HSD17B3
SCHEMBL29640801 0.69 TRPA1 (0.38) KDM1APARP1TRPA1
SCHEMBL20896958 0.69 HTR2A (0.38) KDM1ATSHR
SCHEMBL29699585 0.69 HTR2A (0.38) KDM1ATSHR
SCHEMBL22780705 0.69
SCHEMBL28218152 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106061953-A Compound binding to PPARG but not acting as promoter and pharmaceutical composition for treating diseases related to PPARG comprising the same as active ingredient 现代药品株式会社 2016-10-26 CN disclosed
CN-105189461-A 2,3-disubstituted 1-acyl-4-amino-1,2,3,4-tetrahydroquinoline derivatives and their use as bromodomain inhibitors GLAXOSMITHKLINE IP NO 2 LTD 2015-12-23 CN disclosed